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The molecular machinery underlying neurotransmitter receptor
immobilization at postsynaptic sites is poorly understood. The
NMDA receptor subunit NR1 can form clusters in heterologous
cells via a mechanism dependent on the alternatively spliced
C1 exon cassette in its intracellular C-terminal tail, suggesting
a functional interaction between NR1 and the cytoskeleton. The
yeast two-hybrid screen was used here to identify yotiao, a
novel coiled coil protein that interacts with NR1 in a C1 exon-
dependent manner. Yotiao mRNA (11 kb) is present modestly in
brain and abundantly in skeletal muscle and pancreas. On
Western blots, yotiao appears as an ;230 kDa band that is
present in cerebral cortex, hippocampus, and cerebellum. Bio-
chemical studies reveal that yotiao fractionates with
cytoskeleton-associated proteins and with the postsynaptic
density. With regard to immunohistochemistry, two anti-yotiao
antibodies display a somatodendritic staining pattern similar to
each other and to the staining pattern of NR1. Yotiao was
colocalized by double-label immunocytochemistry with NR1 in
rat brain and could be coimmunoprecipitated with NR1 from
heterologous cells. Thus yotiao is an NR1-binding protein po-
tentially involved in cytoskeletal attachment of NMDA recep-
tors. Consistent with a general involvement in postsynaptic
structure, yotiao was also found to be specifically concentrated
at the neuromuscular junction in skeletal muscle.
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Proper synaptic function requires accurate localization of appro-
priate ion channels and neurotransmitter receptors to the
postsynaptic site. This localization may occur by means of specific
interactions between synaptic membrane proteins and a variety of
anchoring or clustering molecules (Froehner, 1993; Hall and
Sanes, 1993; Sheng and Kim, 1996). These molecules, via inter-
actions with other proteins, may also bring components of down-
stream signaling pathways into the proximity of the appropriate
channel or receptor, thereby increasing the specificity and efficacy
of signal transmission.
The NMDA receptor has been closely scrutinized because it
represents a major subclass of glutamate receptor at excitatory
synapses in the mammalian brain. NMDA receptors are involved
in neural development and excitotoxicity (Constantine-Paton et
al., 1990; Choi, 1995) and in mechanisms of activity-dependent
synaptic plasticity (Bliss and Collingridge, 1993; Lisman and
Harris, 1993). NMDA receptors exist in vivo as heteromultimers
composed of the essential NR1 subunit assembled with various
members of the NR2 subfamily (NR2A–D) (Ishii et al., 1992;
Meguro et al., 1992; Monyer et al., 1992; Kutsuwada et al., 1993;
Sheng et al., 1994). Each NR2 subunit confers distinct properties
on the heteromeric NMDA receptor complex (Monyer et al.,
1994). Further molecular diversity is imparted by alternative
splicing at three sites in the mRNA, which generate eight distinct
NR1 splice variants (Sugihara et al., 1992; Hollmann et al., 1993).
NMDA receptors were first cloned by functional expression
(for review, see Hollmann and Heinemann, 1994), and few
NMDA receptor-associated proteins have been identified in
brain. An important interaction exists between NR2 subunits and
members of the postsynaptic density-95 (PSD-95) family of syn-
aptic proteins (Kornau et al., 1995; Niethammer et al., 1996) (for
review, see Sheng, 1996; Sheng and Kim, 1996; Kornau et al.,
1997). PSD-95 and its close relative, chapsyn-110, have been
shown to cluster NMDA receptors and Shaker K1 channels in
heterologous cells (Kim et al., 1995, 1996), and the Drosophila
PSD-95 homolog Dlg is required for synaptic clustering of Shaker
channels in vivo (Tejedor et al., 1997).
Unlike NR2 subunits, the major splice forms of NR1 do not
interact with PSD-95. Instead, the C-terminal tail of the most
abundant NR1 splice variant (NR1A) interacts with calmodulin
(CaM) at two sites: a high-affinity site within the alternatively
spliced C1 exon cassette and a lower-affinity site in the C0
membrane-proximal region common to all splice variants of NR1
(Ehlers et al., 1996b). CaM binding to NR1 can inhibit NMDA
receptor channel function (Ehlers et al., 1996b). In addition, yeast
two-hybrid screens have revealed an interaction between the C0
region of NR1 and a-actinin-2, a protein known to cross-link
actin filaments (Wyszynski et al., 1997). This interaction suggests
one mechanism by which NMDA receptors can be immobilized
via attachment to the postsynaptic actin cytoskeleton. Aside from
its potential capacity as an anchoring molecule, a-actinin-2 may
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also modulate receptor function by virtue of its competitive
binding with CaM to the tail of NR1 (Wyszynski et al., 1997).
NR1 subunits, in the absence of NR2, can cluster in heterolo-
gous cells via a mechanism dependent on the C1 exon cassette
(Ehlers et al., 1995), suggesting a functional interaction between
C1 and the cytoskeleton, the molecular basis of which has not
been determined. Here we report the identification and charac-
terization of a novel putative cytoskeletal protein that interacts
with the C-terminal tail of NR1 in a C1-dependent manner.
Because of its long, coiled coil nature, we have dubbed this
protein yotiao, after a popular Chinese breakfast victual consist-
ing of long strands of fried dough. Yotiao is specifically concen-
trated in the neuromuscular junction (NMJ) as well as in neuro-
nal synapses, suggesting that it may have a general function in
organizing postsynaptic specializations.
MATERIALS AND METHODS
Yeast two-hybrid screening and analysis of NR1–yotiao interaction. Yeast
two-hybrid screening and assays were performed as described previously
using the L40 yeast strain harboring HIS3 and b-galactosidase (b-gal) as
reporter genes (Kim et al., 1995; Niethammer et al., 1996; Wyszynski et
al., 1997). Approximately 2 3 10 6 clones were screened using a human
brain cDNA library (Clontech, Palo Alto, CA) constructed in the Gal4
activation domain vector pGAD10. The C-terminal constructs of various
NR1 splice variants, Kv1.4, and GluR1, were generated by PCR with
specific primers and subcloned in-frame into pBHA to obtain LexA
fusion proteins. Clone A1.7 ( yotiao), clone A2.10 (a-actinin-2), and
clone NAP1 (CaM) were subcloned into pGAD10 to generate Gal4
activation domain fusion proteins. Deletion constructs of yotiao were
made by PCR using specific primers and were also used to generate Gal4
activation domain fusion proteins. Deletion constructs were tested for
interaction in the yeast two-hybrid assay by using HIS3 and b-gal as
reporter genes.
Yotiao cDNA cloning. The original human yotiao cDNA fragment,
clone A1.7, was used as a hybridization probe to obtain from a 59-Stretch
Plus human brain cDNA l phage library (Clontech) further clones (3-1,
9-1, 21-1, 25-1, and 25-2) that encompassed residues 138–1642 of the
putative yotiao protein. Other methods were used to obtain sequences
encoding residues upstream of amino acid 138. Clones 31-1, 32-3, and
33-2 were obtained from the SuperScript human brain cDNA phagemid
library (Life Technologies, Grand Island, NY) by the GeneTrapper
system (Life Technologies). Clone 41-2 was obtained by 59-rapid ampli-
fication of cDNA ends (RACE) using Marathon-Ready human brain
cDNA (Clontech). All clones were sequenced at an automated sequenc-
ing facility and analyzed using the Wisconsin Sequence Analysis Package
(Genetics Computer Group, Madison WI). The full-length yotiao cDNA
was cloned into pBluescript II (Stratagene, La Jolla, CA) by assembling
four large overlapping fragments consisting of cDNA clones 33-2, 32-3,
25-1, and 21-1 (see Fig. 2). This full-length nucleotide sequence was
deposited in the GenBank database (accession number AF026245).
Northern blots. A human poly(A) mRNA multitissue northern blot
(Clontech) was incubated with 32P-labeled probes prepared from clones
21-1 and 25-1, nonoverlapping fragments of the yotiao cDNA (see Fig. 2).
Blots were hybridized in ExpressHyb hybridization solution (Clontech)
at 68°C for 1 hr, washed under high-stringency conditions (wash 1, 23
SSC and 0.05% SDS at room temperature for 30 min; wash 2, 0.13 SSC
and 0.1% SDS at 50°C for 40 min), and exposed 7 hr at 270°C on XAR-5
film (Eastman Kodak, Rochester, NY).
Antibodies. Anti-yotiao antisera (B5843 and B5844) were raised by
immunizing rabbits with a hexahistidine (H6 )-tagged fusion protein
incorporating residues 747–1279 (contained within clone A1.7; see Fig.
2). Yotiao-specific antibodies were then affinity-purified on a Sulfolink
column (Pierce, Rockford, IL) coupled to the original H6-tagged im-
munogen. The rabbit anti-a-actinin-2 antibody was a gift from Alan
Beggs (Genetics Division, Children’s Hospital and Harvard Medical
School, Boston, MA) and has been described (Wyszynski et al., 1997).
The anti-Kv1.4 antibody has been described (Sheng et al., 1992). The
widely used anti-NR1 monoclonal antibody 54.1 was obtained from
PharMingen (San Diego, CA) (Brose et al., 1993).
Expression constructs and transfections. A yotiao expression construct
was created by subcloning the full-length yotiao cDNA into the KpnI site
(59) and the BglII site (39) of the mammalian expression vector GW1-
CMV (British Biotechnology, Oxford, UK). COS-7 cells were trans-
fected at ;70% confluency in multiwell plates using the Lipo-
fectAMINE method (Life Technologies). Two days after transfection,
cells were harvested for preparation of cell extracts.
Immunoblotting, immunoprecipitation, and immunohistochemistry. For
immunoblotting, transfected COS-7 cells were lysed in radioimmunopre-
cipitation assay (RIPA) buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1%
NP-40, 0.5% deoxycholate, and 0.1% SDS) containing protease inhibi-
tors. After incubation at 4°C for 1 hr, insoluble fractions of cell lysates
were pelleted in a microcentrifuge at 14,000 rpm for 15 min. Crude
synaptosomal membrane fractions from rat brain were prepared as de-
scribed previously (Sheng et al., 1992). Immunoblotting with chemilumi-
nescence reagents was performed as described previously (Sheng et al.,
1993). All antibodies were used at ;1 mg/ml in immunoblotting.
For immunoprecipitation, specific antibodies (5–10 mg/ml) were added
to RIPA cell lysates (;150 mg protein) and incubated at 4°C for 2 hr
followed by protein A-Sepharose (Pharmacia, Piscataway, NJ) for 2 hr.
Immunoprecipitates were washed, eluted, separated by SDS-PAGE, and
analyzed by immunoblotting.
Brain immunohistochemistry was performed on Vibratome-cut 50 mm
floating brain sections from Sprague Dawley rats (;6 weeks of age)
perfused transcardiacally with 4% paraformaldehyde and permeabilized
with 0.1% Triton X-100, as described previously (Sheng et al., 1994). For
protease treatment, brain sections were subjected to light digestion by 15
mg/ml proteinase K (Boehringer Mannheim, Indianapolis, IN) for 10
min at 37°C. Staining was visualized using the Vectastain ABC kit
(Vector Laboratories, Burlingame, CA) and diaminobenzidine (DAB) or
with Cy3 or FITC-conjugated secondary antibodies (Jackson Immu-
noResearch, West Grove PA). In double-labeling experiments, the TSA-
Direct kit (DuPont NEN, Boston, MA) was used to enhance NR1
immunostaining signal.
Muscle immunohistochemistry was performed on 15 mm adult rat
sternomastoid muscle transverse sections lightly fixed with 0.5% parafor-
maldehyde. Yotiao was labeled by B5843 at 2 mg/ml, followed by a Texas
Red-conjugated secondary antibody (Jackson ImmunoResearch). Ace-
tylcholine receptors (AChRs) were labeled with biotinylated
a-bungarotoxin followed by BODIPY-conjugated streptavidin (both
from Molecular Probes, Eugene, OR). Desmin was labeled by a 1:100
dilution of a mouse monoclonal antibody (mAb 1403; Porter and
Froehner, 1983) followed by Texas Red-conjugated secondary antibody
(Jackson ImmunoResearch).
Subcellular and PSD fractionation. Subcellular fractions of whole rat
brain were prepared as described (Huttner et al., 1983). Briefly, rat brain
Dounce homogenates (H) were centrifuged at 1000 3 g to remove nuclei
and other large debris (pelleted in P1). The supernatant (S1) was cen-
trifuged at 10,000 3 g to obtain a crude synaptosomal fraction (P2),
which was subsequently lysed hypo-osmotically and centrifuged at
25,000 3 g to pellet a synaptosomal membrane fraction (LP1). The
supernatant (LS1) was then centrifuged at 165,000 3 g to obtain a crude
synaptic vesicle-enriched fraction (LP2). Concurrently, the supernatant
(S2) above the crude synaptosomal fraction pellet (P2) was centrifuged at
165,000 3 g to obtain a cytosolic fraction (S3) and a light membrane
fraction (P3). The purified PSD fraction was prepared from rat brains as
described previously (Carlin et al., 1980). This PSD fraction was then
subjected to detergent extraction as described (Cho et al., 1992). Samples
were analyzed by SDS-PAGE and immunoblotting as described (Kim et
al., 1996).
RESULTS
Yeast two-hybrid screen for NR1 interacting proteins
The final 105 amino acids (834–938) constituting the C-terminal
tail of the NR1 splice variant NR1A were used as bait to screen
;2 3 106 clones of a human brain cDNA library (also see
Wyszynski et al., 1997). The bait extends from the last transmem-
brane domain of NR1 to the c-terminus of the protein and
contains the C0 membrane proximal region as well as both the C1
and C2 alternatively spliced exon cassettes (Fig. 1, inset). The
yeast two-hybrid screen yielded multiple isolates of two distinct
clones (A1.7 and A2.10) that interacted specifically with NR1A
but not with Shaker-type K1 channel subunits or with the AMPA
receptor subunit GluR1. Clone A2.10 interacted with both the
C0-C1-C2 (NR1A) and C0-C2 (NR1C) splice variants of the
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NR1 C-terminal tail and was found to encode the C-terminal
two-thirds of human a-actinin-2 (described by Wyszynski et al.,
1997). In contrast, clone A1.7 interacted with the C0-C1-C2 but
not with the C0-C2 variant of the NR1 C-terminal tail, implying
that it binds NR1 in a C1 exon-dependent manner. Clone A1.7
contained a 1.6 kb cDNA insert that encoded a fragment of a
large novel protein, which we have named yotiao.
Primary structure of yotiao
By using conventional hybridization screening as well as the
GeneTrapper system (Life Technologies) and 59 RACE, we ob-
tained the presumptive full-length coding sequence of yotiao
from several human brain cDNA libraries. The open reading
frame is 5.1 kb in length and encodes a 1642 amino acid protein
(Fig. 2). We cannot unambiguously assign the starting methionine
of yotiao, because we have not identified an in-frame stop codon
in the 59 untranslated region (UTR). Nevertheless, the veracity of
the assigned N terminus of yotiao is supported by the highly
GC-rich nature of the 59 UTR and a six of seven nucleotide match
in the Kozak sequence around the putative start codon. Further-
more, this coding sequence can be expressed in heterologous cells
to yield a protein of a size roughly consistent with that of
endogenous yotiao in rat brain (see Regional and subcellular
distribution of yotiao protein). The C terminus of the protein,
delineated by an in-frame stop codon, followed by 39 untranslated
region and poly(A) tail, was found in clone 21-1. The accuracy of
the yotiao sequence was confirmed in many areas by sequencing
numerous overlapping clones (Fig. 2) and by checking the assem-
bled sequence against independent expressed sequence tags in
the databases.
Yotiao is a novel protein, and BLAST analysis of the deduced
amino acid sequence did not yield significant homologies, except
weak similarity to coiled-coil regions of proteins such as myosin
heavy chain and intermediate filaments. Yotiao is leucine-rich
throughout, and analysis by the Lupas algorithm predicts many
Figure 1. Yeast two-hybrid analysis of NR1–yotiao interaction. A, C1 exon cassette is necessary for an interaction between yotiao and the NR1
C-terminal tail. NR1 C-terminal tail deletion constructs were subcloned into the bait vector pBHA and assayed by yeast two-hybrid for binding to GAL4
activation domain constructs of yotiao, a-actinin-2, or CaM. Vector only, pGAD10 with no insert. Interaction was determined by activation of the two
reporter genes, HIS3 and b-gal. Inset, Membrane topology of NR1. The intracellular tail consists of the membrane proximal segment C0, and
alternatively spliced exons C1 and C2. B, A 272 amino acid region of yotiao is sufficient for interaction with the NR1 C-terminal tail in a C1-dependent
manner. Clone A1.7 and further deletion constructs of yotiao were tested (as GAL4-activation-domain fusions) by yeast two-hybrid for binding to NR1
C-terminal deletion constructs as in A. Numbers refer to the amino acid residues at the boundaries of each construct. The location of the polypeptide
fragment encoded by clone A1.7 within the full-length yotiao protein is shown.
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long stretches of coiled coil heptad repeats scattered throughout
the length of the protein (Fig. 2) (Lupas et al., 1991).
Yotiao interacts with NR1 in a C1 exon
cassette-dependent manner
Deletion variants of the NR1 C-terminal tail were constructed in
an effort to define the region of NR1 that interacts with yotiao
using yeast two-hybrid assays (Fig. 1A). The C1 exon cassette is
necessary for binding between NR1 and yotiao. The NR1A
C-terminal tail (containing C0-C1-C2) and the C0-C1 constructs
both interacted with yotiao, whereas the NR1C C-terminal tail
(containing C0-C2) and the C0 constructs did not interact (Fig.
1A). In parallel, deletion constructs of clone A1.7 were made to
delimit its region of interaction with NR1. A region of ;270
amino acids in yotiao (970–1241) was sufficient for binding to
NR1 in a C1 exon-dependent manner (Fig. 1B). A further dele-
tion of ;100 amino acids from the C-terminal side abolished the
interaction, but whether this deleted fragment (1145–1241) is
sufficient as well as necessary for NR1 binding remains to be
determined.
Coimmunoprecipitation of yotiao and NR1
We generated rabbit polyclonal antibodies (B5843 and B5844)
against yotiao by using as immunogen an H6-tagged fusion pro-
tein incorporating residues 747–1241 of yotiao (see Fig. 2). The
anti-yotiao antibodies were affinity-purified on a column on which
the original H6-tagged immunogen was immobilized.
To confirm the interaction of the full-length yotiao and NR1
proteins within a cellular context, coimmunoprecipitation exper-
iments were performed using COS-7 cells transfected with both
yotiao and NR1A expression constructs. A mouse monoclonal
antibody against NR1 coimmunoprecipitated the yotiao protein
in addition to NR1 (Fig. 3). The relative specificity of this
coimmunoprecipitation was demonstrated by the inability of yo-
tiao to be coimmunoprecipitated by equal amounts of a control
antibody directed against the Shaker potassium channel Kv1.4.
Conversely, the yotiao antibodies were able to coimmunoprecipi-
tate NR1, although the efficiency of coimmunoprecipitation was
lower than that of the reverse configuration. This difference in
efficiency might be attributed to the fact that the yotiao antibodies
were raised against the very region of the protein that interacts
Figure 2. Primary structure of yotiao. A, Aligned below the schematic of yotiao are the overlapping cDNA clones used to determine its full-length
sequence. A1.7 is the clone isolated by yeast two-hybrid screen using as bait the NR1A C-terminal tail. Hatched regions within the schematic represent
areas of high coiled coil probability as predicted by the Lupas algorithm (Lupas et al., 1991). The region of yotiao prepared as H6-tagged immunogen
is shown aligned with full-length yotiao. B, The deduced primary structure of yotiao is shown in single-letter amino acid code.
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with NR1. Much of the yotiao protein may therefore have been
shielded from the antibody by virtue of its interaction with NR1.
We were unable to obtain coimmunoprecipitation of yotiao with
NR1 from rat brain membrane extracts, as might be predicted
from the differential solubility of these two proteins (see Regional
and subcellular distribution of yotiao protein). The harsh deter-
gent conditions needed to extract NR1 from rat brain membrane
preparations likely disrupted the interaction between NR1 and
the more easily solubilized yotiao protein.
Tissue distribution of yotiao mRNA
A human multitissue Northern blot hybridized under high strin-
gency conditions revealed an 11 kb yotiao transcript that was
present abundantly in skeletal muscle and pancreas, to a lesser
degree in heart and placenta, and modestly in brain (Fig. 4).
Yotiao mRNA was undetectable in lung, liver, and kidney. We
were unable to perform in situ hybridization experiments to
determine the cellular pattern of yotiao mRNA expression in rat
brain, because we do not have the rat cDNA homolog of yotiao.
Regional and subcellular distribution of yotiao protein
Yotiao antibodies were used to study the distribution of yotiao
protein in the rat brain. Western blot analysis using rat brain
membrane fractions gave similar results with both B5843 and
B5844 affinity-purified antibodies. Both antibodies revealed a
major band of ;230 kDa; this compares with the predicted
molecular weight of ;190 kDa based on the amino acid sequence
of yotiao (Fig. 5A). To characterize the specificity of yotiao
antibodies further, COS-7 cells were transfected with an expres-
sion construct containing the full-length yotiao cDNA. Western
blotting with both B5843 and B5844 revealed a major band at
;200 kDa specifically in yotiao-transfected cells but not in control
Kv1.4 or NR1-transfected cells (Fig. 5A) (data not shown). In
addition, multiple specific bands, probably representing yotiao
degradation products, were also seen. The discrepancy in size
between the major polypeptide expressed in heterologous cells
and the endogenous brain protein might be accounted for by
post-translational modifications such as phosphorylation or fatty
acylation that occur more extensively in vivo than in vitro. We
cannot, however, exclude the possibility that our yotiao coding
region is incomplete at the 59 end (see above). Immunoblot
analysis of yotiao-transfected COS-7 cells also revealed a prom-
inent band at ;140 kDa, which may represent a degradation
product of the full-length protein (Fig. 5A).
Western analysis of soluble and membrane fractions from rat
brain indicate that yotiao is predominantly associated with the
membrane (Fig. 5B). Yotiao is widely expressed in brain; the
protein is present at similar levels in crude synaptosomal mem-
brane fractions prepared from cortex, hippocampus, cerebellum,
and subcortical structures (Fig. 5A). Biochemical studies of rat
cerebral cortex revealed a fractionation profile of yotiao that
resembles that of a cytoskeleton-associated protein such as
a-actinin-2 (Fig. 5C). Yotiao is significantly depleted in the cyto-
solic fraction (S3) and enriched in P2 (crude synaptic fraction), P3
(light membrane pellet), and LP2 (crude synaptic vesicle-
enriched fraction). By comparison, however, the integral mem-
brane protein NR1 demonstrates a profile that is more specifi-
cally associated with membrane-containing fractions than yotiao.
Figure 3. Coimmunoprecipitation of yotiao and NR1. Lysates of COS-7
cells doubly transfected with cDNA expression constructs encoding yotiao
and NR1A were immunoprecipitated with antibodies against yotiao,
NR1, or Kv1.4. Immunoprecipitates were then immunoblotted for yotiao
and NR1 as indicated. Input lane contains 10% of the cell lysate used for
the immunoprecipitation reaction. Positions of molecular weight markers
are indicated in kilodaltons. Yt, Yotiao.
Figure 4. Tissue distribution of yotiao mRNA. Poly(A) mRNA multitis-
sue Northern blot was probed with 32P-labeled yotiao cDNA. Positions of
RNA molecular size markers are shown in kilobases. Sk., Skeletal.
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NR1 is highly enriched in P2, P3, and LP1 (lysed synaptosomal
membranes) and virtually absent from S3.
The NMDA receptor subunits including NR1 are components
of the postsynaptic density (for review, see Kennedy, 1993) and
associate tightly with the PSD, resisting extraction by Triton
X-100 and sarkosyl detergents (Fig. 5B). Yotiao is also enriched
in PSD fractions, in which it is resistant to Triton X-100 extrac-
tion (PSD I and II) (Fig. 5B). However, yotiao apparently differs
from NR1 in being extractable by sarkosyl (not enriched in PSD
III). Moreover, it is noteworthy that the degree of yotiao enrich-
ment in PSD fractions is not as great as for NR1 (Fig. 5B). These
differences suggest that yotiao is not as tightly associated with the
PSD as NR1 and may not be as exclusively associated with the
PSD as NR1. In summary, yotiao is widely expressed in rat brain,
and its pattern of subcellular and PSD fractionation is consistent
with an interaction between yotiao and NR1 in synapses in vivo.
However, this synaptic association may be relatively weak, be-
cause yotiao can be stripped from the PSD by sarkosyl.
Immunolocalization of yotiao in rat brain
In immunohistochemical experiments, similar patterns of immu-
nostaining were obtained with both B5843 and B5844 affinity-
purified antibodies, supporting the idea that the immunostaining
pattern observed corresponds to the true distribution of the
yotiao protein (Fig. 6 compare A,G and H,K). Furthermore, no
staining with either antibody was detected when they were pre-
incubated with the H6-tagged immunogen (Fig. 6D–F) (data not
shown). Yotiao is expressed in a somatodendritic pattern in
neurons throughout the rat brain with prominent staining in the
cerebral cortex, hippocampus, and cerebellum (Fig. 6).
In the cerebral cortex, yotiao immunoreactivity was found in
pyramidal neurons as well as in the surrounding neuropil
throughout layers II–VI (Fig. 6A). Pyramidal cell bodies and
their proximal apical dendrites were prominently stained. After
light pretreatment of brain sections with protease, increased yo-
tiao staining was observed in distal dendrites and in the surround-
ing neuropil in a punctate pattern suggestive of synaptic localiza-
tion (Fig. 7A). We attempted to colocalize these puncta with
synaptophysin in double-labeling experiments, but we were un-
successful because synaptophysin staining was incompatible with
protease pretreatment. The punctate somatodendritic and neuro-
pil staining pattern was specific for yotiao, as evidenced by abo-
lition of staining by competition with excess antigen (Fig. 6) (data
not shown).
All regions of the hippocampus contained immunoreactive
neurons (Fig. 6B,H,K). The pyramidal cell bodies of CA1, CA2,
and CA3 were prominently stained. In all three areas, labeled
apical dendrites were observed to extend into the stratum radia-
tum (Fig. 7B). In CA3, the stratum lucidum was relatively in-
tensely stained compared with the stratum radiatum of CA1 and
CA2 (data not shown). Several scattered interneurons were la-
beled within the stratum oriens as well as the stratum radiatum
(Fig. 6H,K). In the dentate gyrus, the granule cell soma were
positive for yotiao, with weaker immunoreactivity in the stratum
moleculare. Scattered neurons in the hilus were stained in a
somatodendritic pattern.
4
Figure 5. Specificity of yotiao antibody: regional distribution and bio-
chemical fractionation of yotiao in rat brain. A, Synaptosomal membrane
preparations from various regions of rat brain were immunoblotted for
yotiao along with lysates from COS-7 cells transfected with yotiao, Kv1.4,
or NR1. Positions of molecular weight markers are indicated in kilodal-
tons. The ;230 kDa band corresponding to endogenous yotiao is indi-
cated. The asterisk indicates the position of the major yotiao band heter-
ologously expressed in COS-7 cells. Yt, Yotiao; WB, whole brain; Ctx,
cortex; Cbl, cerebellum; Hpc, hippocampus; SubCtx, subcortical structures
including brainstem. B, Membrane association and enrichment of yotiao
and NR1 in the PSD, shown by immunoblotting of PSD fractions with
yotiao and NR1 antibodies. PSD fractions were extracted with Triton
X-100 once (PSD I ) or twice (PSD II ) or with Triton X-100 followed by
sarkosyl (PSD III ). Memb, Rat brain crude synaptosomal membrane
fraction. Amount of protein (micrograms) in each lane is indicated. C,
Yotiao demonstrates a biochemical fractionation profile similar to that of
a-actinin-2 and partly overlapping with NR1. The subcellular fractions of
rat brain, as described in Materials and Methods, were immunoblotted for
a-actinin-2, yotiao, and NR1.
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The cerebellum showed prominent staining of Purkinje cells in
all folia. Yotiao immunoreactivity was observed in the cell bodies
and throughout the dendritic arborizations (Fig. 6C, I,L). The
granule cell layer appeared more lightly stained than the molec-
ular layer.
Immunocolocalization of yotiao and NR1 in rat brain
Colocalization of yotiao and NR1 in brain is a prerequisite for
an in vivo association between the two proteins. Double im-
munofluorescence studies showed that yotiao and NR1 immu-
noreactivity indeed colocalized in somatodendritic puncta in
pyramidal neurons of the cerebral cortex (Fig. 7C9, C99). The
somatodendritic pattern of NR1 staining is similar to that
reported previously (Brose et al., 1993; Petralia et al., 1994;
Johnson et al., 1996). The immunostaining patterns of yotiao
and NR1 did not coincide completely, because a minority of
cells demonstrated yotiao staining in the absence of NR1
staining and vice versa (data not shown). This suggests that not
all NR1 protein in the brain is associated with yotiao. Because
not all NR1 splice variants contain the C1 exon cassette, this
result is consistent with the C1 dependence of the interaction
between yotiao and NR1. By the same token, not all yotiao
protein in the brain is associated with NR1, suggesting that
yotiao likely serves functions in neurons other than merely
binding NR1.
Figure 6. Immunohistochemical localization of yotiao in rat brain. Coronal sections were immunostained with yotiao antibodies B5843 (A, C–F,
H, I, L) or B5844 (B, G, J, K ) and visualized by DAB. These antibodies give similar staining patterns. A–C, Yotiao immunoreactivity in cerebral
cortex ( A), hippocampal formation ( B), and cerebellum ( C), with corresponding controls in D–F (antibody preincubated with immunogen). Note
widespread somatodendritic labeling of neurons and diffuse staining of neuropil in neocortex, dentate gyrus, CA1 and CA3 of hippocampal
formation, and cerebellum. G, J, Immunostaining of cell soma and apical dendrites of pyramidal neurons in the cerebral cortex. Staining of basal
dendrites is also observed. H, K, Labeling of CA1 pyramidal cell layer in a somatodendritic manner. Note scattered interneuron immunoreactivity
and neuropil staining in stratum oriens and stratum radiatum. I, L, Staining of Purkinje neurons extending from cell soma throughout major
dendritic arborizations. DG, Dentate gyrus; m, molecular layer; g, granular layer; p, Purkinje cell layer; w, white matter; so, stratum oriens; sr,
stratum radiatum. Scale bars: A–F, 0.5 mm; G–I, 125 mm; J–L, 62.5 mm.
Lin et al. • Yotiao, a Novel Synaptic Protein J. Neurosci., March 15, 1998, 18(6):2017–2027 2023
Immunolocalization of yotiao in rat
neuromuscular junction
By Northern analysis, yotiao mRNA is expressed abundantly in
skeletal muscle (Fig. 4). Consequently, immunohistochemical lo-
calization studies were also directed toward this tissue. Strikingly,
yotiao antibodies showed highly concentrated labeling at the
NMJ, subjacent to AChRs and extending to the perijunctional
membrane (Fig. 8A). Outside of the junctional area, yotiao im-
munoreactivity was also weakly detected in Z lines, the anchoring
point of oppositely oriented actin filaments of adjacent sarcom-
eres (Fig. 8B). Labeling of these structures was eliminated if
commercial rabbit IgG was substituted for the anti-yotiao anti-
bodies or if the antibodies were preincubated with the yotiao
fusion protein (data not shown). The staining pattern of yotiao is
very similar to that of the intermediate filament desmin (de-
scribed in Sealock et al., 1989), with the exception that unlike
desmin, yotiao does not stain the general sarcolemma (Fig. 8C).
The strand-like pattern of yotiao staining subjacent to the AChR
may represent fibrous organization of yotiao (see Fig. 8B). How-
ever, it is also possible that unstained subjunctional nuclei may be
occluding the area of yotiao staining in such a way as to create
these strands. In summary, the staining pattern of yotiao in
muscle suggests that it is a cytoskeleton-associated protein that
may be involved in organization of the NMJ.
DISCUSSION
The NMDA receptor participates in many important functions
and dysfunctions of the nervous system, such as synapse forma-
tion, synaptic plasticity, and excitotoxicity. Elucidation of these
processes requires an understanding of how NMDA receptors are
targeted to particular synapses, how this localization is regulated
during development and synaptic activity, and how NMDA re-
ceptor activity is transduced into the intracellular signals respon-
sible for particular neuronal responses. In an effort to define the
molecular machinery underlying NMDA receptor localization
and function, we have identified yotiao, a novel large coiled coil
protein that interacts with NR1 in a C1 exon cassette-dependent
manner.
The large size and the predicted coiled coil nature of yotiao
allows some speculations about this novel protein. First, yotiao
can likely assemble itself into homomultimers or form heteromul-
timers with related proteins, because coiled coil domains are
known to be sites of homomultimeric and heteromultimeric in-
teractions (Adamson et al., 1993; Blake et al., 1995). Furthermore,
many filamentous cytoskeleton-associated proteins such as myo-
sin heavy chain, tropomyosin, and dystrophin contain extended
coiled coil regions (Gimona et al., 1995; Winder et al., 1995;
Hoppe and Waterston, 1996). By analogy, therefore, yotiao might
also be a filamentous protein that is associated with the cytoskel-
eton. Supporting this idea, the subcellular fractionation pattern of
yotiao is similar to that of a-actinin-2, an actin-binding protein.
Furthermore, in skeletal muscle, the immunostaining pattern of
yotiao is very similar to that of desmin, a type III intermediate
filament; in addition, yotiao staining is associated with Z lines. In
its synaptic and Z line localization, yotiao distribution in skeletal
Figure 7. Localization of yotiao in rat
cerebral cortex and hippocampus, and co-
localization of yotiao and NR1 in pyra-
midal neurons, by confocal immunofluo-
rescence microscopy. A, B, Specific
labeling of distal dendrites of pyramidal
cells and the surrounding neuropil in the
rat cerebral cortex (A) and the CA1 re-
gion of the rat hippocampus (B) in a
punctate pattern suggestive of synaptic
localization. Brain sections were lightly
digested with protease before immuno-
histochemical processing to enhance dis-
tal dendritic and neuropil staining. C9, C0,
Colocalization of yotiao (C9) and NR1
(C0) in immunoreactive puncta in the cell
soma and proximal apical dendrites of
cortical pyramidal neurons. Brain sections
were first stained for yotiao (B5843 visu-
alized by a Cy3-conjugated secondary an-
tibody) followed by immunolabeling for
NR1 (54.1 visualized by tyramide ampli-
fication system, TSA-green). Scale bar: A,
C9, C0, 30 mm; B, 75 mm.
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muscle is remarkably reminiscent of a-actinin (Bloch and Hall,
1983). Intriguingly, a-actinin also binds NR1 in the brain, al-
though to a different site in the NR1 C-terminal tail than yotiao
(Wyszynski et al., 1997). The specific association of yotiao with
the NMJ as well as the PSD suggests a possible role for yotiao in
the organization of multiple kinds of synapse. As a putative
cytoskeleton-associated protein, yotiao may be acting at diverse
synapses to help anchor synaptic membrane proteins to the
cytoskeleton.
Coincident with this putative structural role, yotiao may also
modulate receptor function. NMDA receptors are functionally
dependent on their association with the underlying actin cy-
toskeleton, and a-actinin-2 has been advanced as a candidate
protein that links NMDA receptors to actin (Rosenmund and
Westbrook, 1993; Krupp et al., 1996; Wyszynski et al., 1997).
Yotiao offers an alternative means to connect NMDA receptors
to the cytoskeleton. In addition, yotiao may serve as a molecular
scaffold that couples NMDA receptors to downstream signaling
molecules in a manner similar to PSD-95 (Brenman et al., 1996).
Only a small part of yotiao is required for NR1 binding, leaving
unoccupied many potential areas of interaction with other pro-
teins. The likelihood of such interactions is bolstered by the fact
that coiled coil domains have been identified on many signaling
molecules such as G-proteins, protein kinases, and transcription
factors (Simonds et al., 1993).
Presently, the evidence for in vivo association between yotiao
and NR1 is based on cellular coexpression, subcellular cofrac-
tionation, and subcellular colocalization. The inability to coim-
munoprecipitate these two proteins in vivo is not surprising, given
their differential detergent solubility from synaptic membrane
preparations. A robust demonstration of the interaction will come
from genetic studies, in which loss of function of the yotiao gene
may affect the structure and function of synapses that contain
NMDA receptors. On the other hand, binding NMDA receptors
is not likely to be the sole function of yotiao in the brain. Based
on the incomplete overlap of yotiao and NR1 distribution in brain
and the synaptic localization of yotiao at the NMJ (where NMDA
receptors do not exist), yotiao can be expected to interact
with other receptors or membrane proteins, consistent with a
general role in synaptic organization. Additionally, as a putative
cytoskeleton-associated protein, yotiao may be involved in
protein–protein interactions outside of the synapse, perhaps as
part of the transport machinery that targets receptor-containing
vesicles to the plasma membrane. We have not definitively local-
ized yotiao to central synapses because of incompatibility
of immunolabeling conditions for a-yotiao antibodies and
a-synaptophysin antibodies. Therefore, the localization of yotiao
at neuronal synapses remains to be confirmed, ideally by electron
microscopy.
The dependence of the yotiao–NR1 interaction on the C1
exon cassette is intriguing because of the importance assigned
to this alternatively spliced exon cassette by previous studies.
This 37 amino acid region has been implicated in aggregation
of NR1 in heterologous cells and in modulation of NMDA
receptor function in Xenopus oocytes (Durand et al., 1992;
Ehlers et al., 1995). It has also been identified as a site of
phosphorylation by PKC and as a high-affinity calmodulin
binding site (Tingley et al., 1993; Ehlers et al., 1996b). As such,
the C1 exon cassette has been proposed to serve as a modifiable
targeting motif and a regulator of NMDA receptor function
(Ehlers et al., 1996a). Our findings indicate that the C1 exon
may also function to mediate an interaction with the cytoskel-
eton through the binding of yotiao.
In light of its C1 exon dependence, the interaction between
yotiao and NR1 may be regulated by three distinct mecha-
nisms: (1) alternative splicing of the C1 exon cassette, (2)
phosphorylation of the C1 exon cassette, and (3) CaM binding
Figure 8. Immunohistochemical localization of yotiao in rat skeletal
muscle. Yotiao is predominantly localized subjacent to AChRs in the
NMJ and demonstrates a staining pattern similar to the intermediate
filament desmin. Yotiao was labeled by B5843 followed by Texas Red-
conjugated secondary antibody (A, B; red) or BODIPY-conjugated sec-
ondary antibody (C; green). AChR was labeled with biotinylated
a-bungarotoxin followed by BODIPY-conjugated streptavidin (A, B;
green). Desmin was labeled with mAb 1403 followed by Texas Red-
conjugated secondary antibody (C; red). A, Large-field view showing
yotiao expression at every NMJ. The sarcolemma is stained only in the
perijunctional region but not beyond. B, High-magnification view of the
NMJ reveals yotiao staining subjacent to AChR staining. Arrowheads
indicate Z lines weakly stained for yotiao. C, Similar pattern of yotiao and
desmin localization in the subsynaptic region. However, note absence of
yotiao staining, but presence of desmin staining, on the general sarco-
lemma. As is common with transverse sections, distinct Z lines are not
apparent in this view, but Z-line staining by mAb 1403 has been docu-
mented (Sealock et al., 1989). Scale bar: A, 25 mm; B, 5 mm; C, 10 mm.
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to the C1 exon cassette. Alternative splicing of the NR1
subunit can act through splice-specific interactors such as yo-
tiao to differentially localize or anchor distinct subsets of
NMDA receptors. Differential subcellular localization by vir-
tue of subunit-specific or splice variant-specific interactions
could be exploited to create glutamatergic synapses with dis-
tinct pharmacological and physiological properties within the
same neuron (Rubio and Wenthold, 1997). Activity-dependent
phosphorylation or CaM binding to C1 could regulate the
localization or cytoskeletal attachment of a subset of NR1 by
enhancing or disrupting its interaction with proteins such as
yotiao. Whether yotiao competes with CaM binding to NR1
and whether the yotiao–NR1 interaction is regulated by PKC
phosphorylation of the C1 exon are interesting questions that
remain to be answered. Such mechanisms may affect receptor
localization and activity and may contribute to the structural
and functional plasticity of synapses.
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